Mitomycin
Novel treatment shows promise for corneal neovascularization
The avascular nature of the cornea is necessary for optical clarity and optimal vision.
Phase 3 trials of nonsurgical therapy for low-grade bladder cancer meet primary endpoints
Two phase 3 trials that evaluated a nonsurgical therapy for certain patients with bladder cancer met their primary endpoints, according to the agent’s manufacturer.
Topical medications for conjunctival tumors have pluses and minuses
MONTEREY, Calif. — Interferon alpha-2b, 5-fluorouracil and mitomycin C can all be used topically for conjunctival tumors, Lauren A. Dalvin, MD, said at the Women in Ophthalmology Summer Symposium.
Sub-Tenon injection of mitomycin C may have advantages over sponge application
FDA approves Jelmyto for low-grade upper tract urothelial cancer
The FDA approved mitomycin gel for the treatment of low-grade upper tract urothelial cancer.
Intraoperative, postoperative MMC helps control IOP in Ahmed glaucoma valve implantation
WASHINGTON — Patients undergoing Ahmed glaucoma valve implantation who received intraoperative and postoperative mitomycin C experienced better IOP control and required fewer glaucoma drops for up to 12 months after surgery, according to a speaker here.
New ablation profile may allow for deep PRK ablation without use of mitomycin C
MARRAKECH, Morocco — A new ablation algorithm for transepithelial PRK effectively reduces haze formation and allows for the correction of even high myopia and myopic astigmatism without the use of mitomycin C, according to a study.
Intracameral platelet-rich plasma shows efficacy for severe, chronic hypotony
Intracameral platelet-rich plasma injected into the anterior chamber can treat cases of chronic hypotony that are nonresponsive to other treatment options, according to Jorge L. Alió, MD, PhD.
Conjunctival lesion in a middle-aged woman
A 50-year-old woman presented to an outside ophthalmologist with a 2-month history of irritation and discharge after injury to the left eye with a mascara brush. Her exam was notable for conjunctival injection and a nasal conjunctival scar. She was treated with erythromycin ointment and a topical steroid with improvement of her symptoms; however, her conjunctival scar remained unchanged, so she was referred to Tufts Medical Center for evaluation. Before this, the patient had no ocular issues. She was otherwise healthy with no medical history or prescribed medications. Her social history was notable for a 30 pack-year smoking history, but she had recently quit smoking.